Fairmount Funds Management LLC Amarin Corp Plcuk Transaction History

Fairmount Funds Management LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$1.13 - $3.69 $1.64 Million - $5.36 Million	1,451,600 Added 35.12%	5,584,837 $8.32 Million
Q1 2022 May 16, 2022	BUY	$2.85 - $3.73 $4.66 Million - $6.1 Million	1,635,000 Added 65.45%	4,133,237 $13.6 Million
Q4 2021 Feb 14, 2022	SELL	$3.24 - $5.18 $32,400 - $51,800	-10,000 Reduced 0.4%	2,498,237 $8.42 Million
Q3 2021 Nov 15, 2021	SELL	$3.94 - $5.84 $98,500 - $146,000	-25,000 Reduced 0.99%	2,508,237 $12.8 Million
Q2 2021 Aug 13, 2021	BUY	$4.26 - $6.5 $3.94 Million - $6.01 Million	925,000 Added 57.52%	2,533,237 $11.1 Million
Q1 2021 May 14, 2021	BUY	$5.03 - $8.8 $503,000 - $880,000	100,000 Added 6.63%	1,608,237 $9.99 Million
Q3 2020 Nov 12, 2020	BUY	$3.64 - $7.76 $382,200 - $814,800	105,000 Added 7.48%	1,508,237 $6.35 Million
Q2 2020 Aug 04, 2020	BUY	$4.78 - $8.26 $2.54 Million - $4.39 Million	531,523 Added 60.97%	1,403,237 $9.71 Million
Q1 2020 May 08, 2020	BUY	$4.0 - $21.53 $120,000 - $645,900	30,000 Added 3.56%	871,714 $3.49 Million
Q4 2019 Feb 12, 2020	BUY	$13.94 - $24.12 $11.7 Million - $20.3 Million	841,714 New	841,714 $18 Million

176

65.1M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $222M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Fairmount Funds Management LLC, based on Form 13F filings with the SEC.

Stay updated on Fairmount Funds Management LLC with notifications on news.